Furthermore, the PPARγ ligand RWJ-241947 (MCC-555) may enhance the apoptosis of MM cells induced by arsenic trioxide [74]; therefore, it is worthwhile to further investigate the potential usefulness of a combination use of TZD and existing chemotherapeutic agents for the treatment of MM. Here, PPARG is linked to Miyoshi myopathy.